{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:35:46Z","timestamp":1793223346233,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00417-026-07291-4","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T03:38:49Z","timestamp":1779853129000},"page":"2611-2621","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Semaglutide and risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) in type 2 diabetes mellitus: A systematic review and meta-analysis"],"prefix":"10.1007","volume":"264","author":[{"given":"Stamatios","family":"Lampsas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysa","family":"Agapitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Oikonomou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Siasos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Theodossiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Tsivgoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaia","family":"Lambadiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irini","family":"Chatziralli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"7291_CR1","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","volume":"7","author":"SL Kristensen","year":"2019","unstructured":"Kristensen SL, Rorth R, Jhund PS, Docherty KF, Sattar N, Preiss D, Kober L, Petrie MC, McMurray JJV (2019) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes Endocrinol 7:776\u2013785. https:\/\/doi.org\/10.1016\/S2213-8587(19)30249-9","journal-title":"Lancet Diabetes Endocrinol"},{"key":"7291_CR2","doi-asserted-by":"publisher","first-page":"106346","DOI":"10.1016\/j.ejim.2025.05.011","volume":"140","author":"L Ozbek","year":"2025","unstructured":"Ozbek L, Guldan M, Fidan DG, Abdel-Rahman SM, Kanbay M (2025) Nonarteritic anterior ischemic optic neuropathy and glucagon-like peptide-1 receptor agonists: Evaluating a potential association. Eur J Intern Med 140:106346. https:\/\/doi.org\/10.1016\/j.ejim.2025.05.011","journal-title":"Eur J Intern Med"},{"key":"7291_CR3","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1177\/19322968241268050","volume":"18","author":"DC Klonoff","year":"2024","unstructured":"Klonoff DC, Hui G, Gombar S (2024) Real-World Evidence Assessment of the Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide. J Diabetes Sci Technol 18:1517\u20131518. https:\/\/doi.org\/10.1177\/19322968241268050","journal-title":"J Diabetes Sci Technol"},{"key":"7291_CR4","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1056\/NEJMra1413352","volume":"372","author":"V Biousse","year":"2015","unstructured":"Biousse V, Newman NJ (2015) Ischemic Optic Neuropathies. N Engl J Med 372:2428\u20132436. https:\/\/doi.org\/10.1056\/NEJMra1413352","journal-title":"N Engl J Med"},{"key":"7291_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00041327-199403000-00011","volume":"14","author":"LN Johnson","year":"1994","unstructured":"Johnson LN, Arnold AC (1994) Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California. J Neuroophthalmol 14:38\u201344","journal-title":"J Neuroophthalmol"},{"key":"7291_CR6","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1016\/j.ophtha.2016.08.017","volume":"123","author":"DM Cestari","year":"2016","unstructured":"Cestari DM, Gaier ED, Bouzika P, Blachley TS, De Lott LB, Rizzo JF, Wiggs JL, Kang JH, Pasquale LR, Stein JD (2016) Demographic, Systemic, and Ocular Factors Associated with Nonarteritic Anterior Ischemic Optic Neuropathy. Ophthalmology 123:2446\u20132455. https:\/\/doi.org\/10.1016\/j.ophtha.2016.08.017","journal-title":"Ophthalmology"},{"key":"7291_CR7","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/s0002-9394(14)72557-7","volume":"118","author":"SS Hayreh","year":"1994","unstructured":"Hayreh SS, Joos KM, Podhajsky PA, Long CR (1994) Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 118:766\u2013780. https:\/\/doi.org\/10.1016\/s0002-9394(14)72557-7","journal-title":"Am J Ophthalmol"},{"issue":"Pt 1","key":"7291_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/eye.1995.13","volume":"9","author":"SJ Talks","year":"1995","unstructured":"Talks SJ, Chong NH, Gibson JM, Dodson PM (1995) Fibrinogen, cholesterol and smoking as risk factors for non-arteritic anterior ischaemic optic neuropathy. Eye (Lond) 9(Pt 1):85\u201388. https:\/\/doi.org\/10.1038\/eye.1995.13","journal-title":"Eye (Lond)"},{"key":"7291_CR9","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1001\/archopht.1997.01100160573008","volume":"115","author":"DM Jacobson","year":"1997","unstructured":"Jacobson DM, Vierkant RA, Belongia EA (1997) Nonarteritic anterior ischemic optic neuropathy. A case-control study of potential risk factors. Arch Ophthalmol 115:1403\u20131407. https:\/\/doi.org\/10.1001\/archopht.1997.01100160573008","journal-title":"Arch Ophthalmol"},{"key":"7291_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.orcp.2025.01.011","volume":"19","author":"M Azab","year":"2025","unstructured":"Azab M, Pasina L (2025) Semaglutide: Nonarteritic Anterior Ischemic Optic Neuropathy in the FDA adverse event reporting system - A disproportionality analysis. Obes Res Clin Pract 19:77\u201379. https:\/\/doi.org\/10.1016\/j.orcp.2025.01.011","journal-title":"Obes Res Clin Pract"},{"key":"7291_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.orcp.2025.03.001","volume":"19","author":"A Procacci","year":"2025","unstructured":"Procacci A, Poluzzi E, De Ponti F, Raschi E (2025) Disproportionality analysis on semaglutide and nonarteritic anterior ischemic optic neuropathy in the FDA adverse event reporting system: An emerging pharmacovigilance signal? Obes Res Clin Pract 19:178\u2013180. https:\/\/doi.org\/10.1016\/j.orcp.2025.03.001","journal-title":"Obes Res Clin Pract"},{"key":"7291_CR12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hrobjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"7291_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6947-7-16","volume":"7","author":"C Schardt","year":"2007","unstructured":"Schardt C, Adams MB, Owens T, Keitz S, Fontelo P (2007) Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inf Decis Mak 7:16. https:\/\/doi.org\/10.1186\/1472-6947-7-16","journal-title":"BMC Med Inf Decis Mak"},{"key":"7291_CR14","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hrobjartsson A, Kirkham J, Juni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schunemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"7291_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, Jaeschke R, Rind D, Meerpohl J, Dahm P, Schunemann HJ (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64:383\u2013394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026","journal-title":"J Clin Epidemiol"},{"key":"7291_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/jrsm.11","volume":"1","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W, Cheung MW (2010) Outlier and influence diagnostics for meta-analysis. Res Synth Methods 1:112\u2013125. https:\/\/doi.org\/10.1002\/jrsm.11","journal-title":"Res Synth Methods"},{"key":"7291_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ajo.2025.02.025","volume":"274","author":"NJ Abbass","year":"2025","unstructured":"Abbass NJ, Nahlawi R, Shaia JK, Allan KC, Kaelber DC, Talcott KE, Singh RP (2025) The Effect of Semaglutide and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic Neuropathy. Am J Ophthalmol 274:24\u201331. https:\/\/doi.org\/10.1016\/j.ajo.2025.02.025","journal-title":"Am J Ophthalmol"},{"key":"7291_CR18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1001\/jamaophthalmol.2024.6555","volume":"143","author":"CX Cai","year":"2025","unstructured":"Cai CX, Hribar M, Baxter S, Goetz K, Swaminathan SS, Flowers A, Brown EN, Toy B, Xu B, Chen J, Chen A, Wang S, Lee C, Leng T, Ehrlich JR, Barkmeier A, Armbrust KR, Boland MV, Dorr D, Boyce D, Alshammari T, Swerdel J, Suchard MA, Schuemie M, Bu F, Sena AG, Hripcsak G, Nishimura A, Nagy P, Falconer T, DuVall SL, Matheny M, Viernes B, O\u2019Brien W, Zhang L, Martin B, Westlund E, Mathioudakis N, Fan R, Wilcox A, Lai A, Stocking JC, Takkouche S, Lee LH, Xie Y, Humes I, McCoy DB, Adibuzzaman M, Areaux RG Jr., Rojas-Carabali W, Brash J, Lee DA, Weiskopf NG, Mawn L, Agrawal R, Morgan-Cooper H, Desai P, Ryan PB (2025) Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy. JAMA Ophthalmol 143:304\u2013314. https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.6555","journal-title":"JAMA Ophthalmol"},{"key":"7291_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ophtha.2024.10.030","volume":"132","author":"CC Chou","year":"2025","unstructured":"Chou CC, Pan SY, Sheen YJ, Lin JF, Lin CH, Lin HJ, Wang IJ, Weng CH (2025) Association between Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy: A Multinational Population-Based Study. Ophthalmology 132:381\u2013388. https:\/\/doi.org\/10.1016\/j.ophtha.2024.10.030","journal-title":"Ophthalmology"},{"key":"7291_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40942-024-00620-x","volume":"10","author":"J Grauslund","year":"2024","unstructured":"Grauslund J, Taha AA, Molander LD, Kawasaki R, Moller S, Hojlund K, Stokholm L (2024) Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes. Int J Retina Vitreous 10:97. https:\/\/doi.org\/10.1186\/s40942-024-00620-x","journal-title":"Int J Retina Vitreous"},{"key":"7291_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ajo.2025.05.007","volume":"277","author":"M Lakhani","year":"2025","unstructured":"Lakhani M, Kwan ATH, Mihalache A, Popovic MM, Nanji K, Xie JS, Feo A, Rabinovitch D, Shor R, Sadda S, Sarraf D, Hurley B, Margolin EA, Kertes PJ, Chaudhary V, Muni RH (2025) Association of Glucagon-Like Peptide-1 Receptor Agonists With Optic Nerve and Retinal Adverse Events: A Population-Based Observational Study Across 180 Countries. Am J Ophthalmol 277:148\u2013168. https:\/\/doi.org\/10.1016\/j.ajo.2025.05.007","journal-title":"Am J Ophthalmol"},{"key":"7291_CR22","doi-asserted-by":"publisher","unstructured":"Hathaway JT, Shah MP, Hathaway DB, Zekavat SM, Krasniqi D, Gittinger JW Jr., Cestari D, Mallery R, Abbasi B, Bouffard M, Chwalisz BK, Estrela T, Rizzo JF 3rd (2024) Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide. JAMA Ophthalmol 142:732\u2013739. https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.2296","DOI":"10.1001\/jamaophthalmol.2024.2296"},{"key":"7291_CR23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1001\/jamaophthalmol.2025.0349","volume":"143","author":"AY Hsu","year":"2025","unstructured":"Hsu AY, Kuo HT, Wang YH, Lin CJ, Shao YC, Chiang CC, Hsia NY, Lai CT, Tseng H, Wu BQ, Chen HS, Tsai YY, Hsu MY, Wei JC (2025) Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy Risk Among Patients With Diabetes. JAMA Ophthalmol 143:400\u2013407. https:\/\/doi.org\/10.1001\/jamaophthalmol.2025.0349","journal-title":"JAMA Ophthalmol"},{"key":"7291_CR24","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1111\/dom.16316","volume":"27","author":"E Simonsen","year":"2025","unstructured":"Simonsen E, Lund LC, Ernst MT, Hjellvik V, Hegedus L, Hamann S, Jorstad OK, Gulseth HL, Karlstad O, Pottegard A (2025) Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: A Danish-Norwegian cohort study. Diabetes Obes Metab 27:3094\u20133103. https:\/\/doi.org\/10.1111\/dom.16316","journal-title":"Diabetes Obes Metab"},{"key":"7291_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12886-025-04096-7","volume":"25","author":"T Zhao","year":"2025","unstructured":"Zhao T, Zheng L, Feng Y, Lao M, Huang Y, Wu G (2025) Association between various dosage forms of semaglutide and ocular adverse events in a real-world setting. BMC Ophthalmol 25:248. https:\/\/doi.org\/10.1186\/s12886-025-04096-7","journal-title":"BMC Ophthalmol"},{"key":"7291_CR26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12886-025-03958-4","volume":"25","author":"H Ahmadi","year":"2025","unstructured":"Ahmadi H, Hamann S (2025) Anterior ischemic optic neuropathy in patients treated with semaglutide: report of four cases with a possible association. BMC Ophthalmol 25:132. https:\/\/doi.org\/10.1186\/s12886-025-03958-4","journal-title":"BMC Ophthalmol"},{"key":"7291_CR27","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.molmet.2017.08.010","volume":"6","author":"LL Baggio","year":"2017","unstructured":"Baggio LL, Ussher JR, McLean BA, Cao X, Kabir MG, Mulvihill EE, Mighiu AS, Zhang H, Ludwig A, Seeley RJ, Heximer SP, Drucker DJ (2017) The autonomic nervous system and cardiac GLP-1 receptors control heart rate in mice. Mol Metab 6:1339\u20131349. https:\/\/doi.org\/10.1016\/j.molmet.2017.08.010","journal-title":"Mol Metab"},{"key":"7291_CR28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/aos.17473","volume":"103","author":"A Amini","year":"2025","unstructured":"Amini A, Hamann S, Larsen M (2025) Semaglutide and non-arteritic anterior ischaemic optic neuropathy: Review and interpretation of reported association. Acta Ophthalmol 103:615\u2013621. https:\/\/doi.org\/10.1111\/aos.17473","journal-title":"Acta Ophthalmol"},{"key":"7291_CR29","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jodar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsboll T, Investigators S- (2016) Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 375:1834\u20131844. https:\/\/doi.org\/10.1056\/NEJMoa1607141","journal-title":"N Engl J Med"},{"key":"7291_CR30","doi-asserted-by":"publisher","first-page":"e76653","DOI":"10.1371\/journal.pone.0076653","volume":"8","author":"T Chen","year":"2013","unstructured":"Chen T, Song D, Shan G, Wang K, Wang Y, Ma J, Zhong Y (2013) The association between diabetes mellitus and nonarteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis. PLoS ONE 8:e76653. https:\/\/doi.org\/10.1371\/journal.pone.0076653","journal-title":"PLoS ONE"},{"key":"7291_CR31","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00417-021-05522-4","volume":"260","author":"IP Chatziralli","year":"2022","unstructured":"Chatziralli IP, Kazantzis D, Chatzirallis AP, Machairoudia G, Papageorgiou EG, Theodossiadis GP, Psaltopoulou T, Theodossiadis PG, Sergentanis TN (2022) Cardiometabolic factors and risk of non-arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol 260:1445\u20131456. https:\/\/doi.org\/10.1007\/s00417-021-05522-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7291_CR32","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijcard.2022.06.027","volume":"364","author":"CH Kim","year":"2022","unstructured":"Kim CH, Hwang IC, Choi HM, Ahn CH, Yoon YE, Cho GY (2022) Differential cardiovascular and renal benefits of SGLT2 inhibitors and GLP1 receptor agonists in patients with type 2 diabetes mellitus. Int J Cardiol 364:104\u2013111. https:\/\/doi.org\/10.1016\/j.ijcard.2022.06.027","journal-title":"Int J Cardiol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07291-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07291-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07291-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:53:46Z","timestamp":1789455226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07291-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["7291"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07291-4","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study does not involve any human subjects or animal and does not require disclosure to the rights.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}